期刊文献+

PPAR-γ2基因Pro12Ala多态性与2型糖尿病视网膜病变的相关性研究 被引量:2

Association of Pro12Ala polymorphism of PPAR-γ2 Gene and diabetic retinopathy in type 2 diabetes
暂未订购
导出
摘要 目的:研究过氧化物酶体增殖物激活受体-γ2(PPAR-γ2)基因Pro12Ala多态性与山西地区汉族人群2型糖尿病性视网膜病变(DR)的相关性。方法:选取年龄40~70岁、糖尿病病程10~20a、血压<140/90mmHg且不合并糖尿病肾病的2型糖尿病患者90例,其中无DR组(NDR组)、非增生型DR组(BDR组)和增生型DR组(PDR组)各30例,采用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)分析技术,对所有患者PPAR-γ2基因Pro12Ala多态性位点进行基因分型。结果:该研究人群中存在2种等位基因和3种基因型,其中NDR组中基因型PP,PA,AA分别为40.0%,53.3%和6.7%,BDR组分别为70.0%,30.0%和0%,PDR组分别为76.7%,23.3%和0%;三组间比较,基因型频率(χ2=10.351)和等位基因频率(χ2=10.208)的差异均有统计学意义(P<0.05)。Logistic回归分析结果显示Pro12Ala基因多态性是DR发生的危险因素。结论:PPAR-γ2基因Pro12Ala多态性与山西地区部分汉族人群2型糖尿病视网膜病变有关,且可能是抑制其发生的保护性因子。 AIM: To observe the relationship between Prol2Ala polymorphism of peroxisome proliferator activated receptor-γ2 (PPAR-γ2) gene and diabetic retinopathy (DR) with type 2 diabetic mellitus (T2DM) of the Han nationality in Shanxi province. METHODS: Totally 90 patients with T2DM were selected into our research, who were at the age of 40 to 70 years old, diabetic duration from 10 to 20 years, blood pressure 〈140/90mmHg, and without diabetic nephropathy. Thirty persons were respectively divided into non-DR (NDR) group, nonproliferative-DR (BDR) group and proliferative-DR (PDR) group according to the result of ophthalmology examination. The genotypes of Pro12Ala polymorphism of PPAR-γ2 gene were determined by polymerase chain reaction- restriction fragment length polymorphisms (PCR-RFLP) assay in all the patients. RESULTS. PCR results showed that there were 2 alleles and 3 genotypes in the groups. The frequency of genotype PP, PA, AA were 40.0%, 53.3%, 6.7% in NDR group, 70.0%, 30.0%, 0.0% in BDR group, 76.7%, 23.3%, 0% in PDR group, respectively. The allele frequency (X2 = 10. 208) and gene frequency (χ2= 10. 351 ) were statistically significant (P〈0.05) in these groups. Logistic regressionanalysis showed that Prol2Ala polymorphism was a dangerous factor in the incidence of DR. CONCLUSION: The alanine variant of Prol2Ala polymorphism of PPAR-γ2 gene is associated with DR in type 2 diabetes among the Hans in Shanxi area, and the Ala allele might be a protective factor for the development of diabetic retinopathy.
出处 《国际眼科杂志》 CAS 2013年第6期1108-1111,共4页 International Eye Science
关键词 2型糖尿病 糖尿病视网膜病变 过氧化物酶体 增殖物激活受体 基因多态性 type 2 diabetes mellitus diabeticretinopathy peroxisome proliferator activated receptor gene polymorphism
  • 相关文献

参考文献11

  • 1Gouda HN, Sagoo GS, Harding AH,et al. The association between the peroxisome prolife- rator- activated receptor gamma2 (PPARG2) Prol2Ala gene variant and type 2 diabetes mellitus: a HuGE review and meta-analysis. Am J Epidemiol 2010;171 (6) :645- 655.
  • 2Meshkani R, Taghikhani M, Larijani B,et al. Prol2Ala polymorphism of the pemxisome proliferator-activated receptor-gamma2 (PPARgamma-2) gene is associated with greater insulin sensitivity and decreased risk of type 2 diabetes in an Iranian population. Clin Chem Lab Med 2007 ;45 (4) :477-482.
  • 3傅健,池上博司,吕远栋,徐伟红,谢海宝,荻原俊男.过氧化物酶体增殖物激活受体γ_2基因Pro^(12)→Ala可能是我国汉族人2型糖尿病的保护性等位基因[J].中华糖尿病杂志(1006-6187),2005,13(5):363-365. 被引量:19
  • 4Herrmann SM, Ringel J, Wang JG, et al. Peroxisome proliferator- activated receptor-gamma2 polymorphism Prol2Ala is associated with nephropathy in type 2 diabetes: The Berlin Dia- betes Mellitus ( BeDiaM ) Study. Diabetes 2002 ;51 ( 8 ) : 2653- 2657.
  • 5李丽芳,刘丽梅,郑泰山,汪年松,王峰.PPARγ2基因P12A多态性与上海地区汉族人群2型糖尿病肾病[J].上海交通大学学报(医学版),2008,28(4):376-379. 被引量:6
  • 6Costa V, Ciccodicola A. Is PPARG the key gene in diabetic retinopathy? Br J Pharmacol 2012 ; 165 ( 1 ) : 1-3.
  • 7Yen C J, Beamer BA, Negri C,et al. Molecular scanning of the human peroxisome proliferator activated receptor gamma (hPPAR gamma ) gene in diabetic Caucasians: identification of a Prol2Ala PPAR gamma 2 missense mutation. Biochem Biophys Res Commun 1997 ; 241 ( 2 ) : 270-274.
  • 8Malecki MT, Cyganek K, Mirkiewicz-Sieradzka B, et al. Alanine variant of the Prol2Ala polymorphism of the PPAR gamma gene might be associat-ed with decreased risk of diabetic retinopathy in type 2 diabetes. Diabets Res Clin Pract 2008 ;80( 1 ) : 139-145.
  • 9Petrovic M, Kunej T, Peterlin B, et al. Gly482Ser polymorphism of the pero- xisome proliferatoractivated receptor-g2 coactivator-1 gene might be a risk factor for diabetic retinopathy in Slovene population (Caucasians) with type 2 diabetes and the Prol2Ala poly- merphism of the PPARg gene is not. Diabetes Metab Res Rev 2005 ;21:470-474.
  • 10Costa V, Casamassimi A, Esposito K, et al. Characterization of a novel polymorphism in PPARG regulatory region associated with type 2 diabetes and dia- betie retinopathy in Italy. J Biomed Biotechnol 2009; 2009 : 126917.

二级参考文献25

  • 1Kubota N, Terauchi Y, Miki H, et al.PPARγ mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol Cell, 1999,4:597-609.
  • 2Mori H, Ikegami H,Kawaguchi Y, et al. The Pro12→Ala Substitution in PPARγ Is Associated With Resistance to Development of Diabetes in the General Population. Diabetes, 2001, 50:891-894.
  • 3Yamauchi T, Kamon J, Waki H, et al. The mechanisms by which both heterozygous PPARγ deficiency and PPARγ agonist improve insulin resistance. J Biol Chem, 2001,276: 41245-41254.
  • 4Steppan CM, Bailey ST, Bhat S, et al. The hormone resistin links obesity to diabetes.Nature,2001,409:307-312.
  • 5Yen CJ, Beamer BA, Negri C, et al. Molecular scanning of the human peroxisome proliferator activiated receptor gamma(hPPARγ)gene in diabetic Caucasians: identification of a Pro12 Ala PPARγ2 missense mutation. Biochem Biophys Res Commun,1997,241:270-274.
  • 6Deeb SS,Fajas L, Nemoto M, et al. A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet,1998, 20:284-287.
  • 7Valve R,Sivenius K,Miettinen R, et al. Two polymorphisms in the peroxisome proliferator-activated receptor-γ gene are associated with severe overweight among obese women. J Clin Endocrinol Metab,1999,84:3708-3712.
  • 8EK J, Urhammer SA, Sorensen TIA, et al. Homozygosity of the Pro12Ala variant of the peroxisome proliferator-activated receptor-γ2(PPARγ2):divergent modulating effects on body mass index in obese and lean Caucasian men.Diabetologia, 1999,42:892-895.
  • 9Beamer BA,Yen CJ, Andersen RE, et al. Association of the Pro12Ala variant in the peroxisome proliferator-activiated receptor-γ2 gene with obesity in two Caucasian populations.Diabetes, 1998,47:1806-1808.
  • 10Katavetin P, Eiam-Ong S, Suwanwalaikorn S. Pioglitazone reduces urinary protein and urinary transforming growth factor-beta excretion in patients with type 2 diabetes and overt nephropathy [ J]. J Med Assoc Thai, 2006, 89(2): 170-177.

共引文献23

同被引文献14

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部